|
Latest Medical & OCAN News Articles
The Ovarian Cancer Alliance of Nevada wants to help extend your knowledge by keeping you informed about the latest happenings in this area of your health. They consist of articles not only about medical breakthroughs, but of success, hope, and actions. The following links are to articles for the current month, that have appeared in newspapers, publications and TV stations from sources throughout both the U.S. and world wide, and are available with on-line editions. Each listing has a short opening paragraph of the article. The listing of the links are by date published, with the most recent found listed first.
For archived articles prior to the current calendar month, please see: Ovarian Cancer Archived News
May 2007
May 30, 2007 - "NewsRx", Atlanta, GA
Study pries into ovarian cancer's deadly secrets
A new University of Michigan Medical School study sheds light on cell defects that lead to one common type of ovarian cancer and puts forth a promising new mouse model that already is being used for preclinical drug testing.
May 30, 2007 - "NewsRx", Atlanta, GA
Data on ovarian cancer published by researchers at Johns Hopkins University
Scientists discuss in "Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells" new findings in ovarian cancer. According to a study from the United States, "Fatty acid synthase (FAS), the enzyme responsible for the de novo synthesis of fatty acids, is highly expressed in ovarian cancers and most common human carcinomas.
May 30, 2007 - "NewsRx", Atlanta, GA
New cancer therapy study findings recently were reported by researchers at Arizona Cancer Center
A report, "Maximizing the delivery of intraperitoneal therapy while minimizing drug toxicity and maintaining quality of life," is newly published data in Seminars In Oncology. According to recent research from the United States,
May 28, 2007 - "Reuters Health", NYC, NY
Transvaginal sonographic screening may catch ovarian cancer early
Transvaginal sonography (TVS) screening is associated with a reduction in ovarian cancer stage at detection and with increased case-specific survival, new research shows. However, TVS screening is not helpful in diagnosing ovarian malignancies in women with normal ovarian volumes. Ovarian cancer is known to be the most deadly of all gynecologic malignancies, due in large part to its typically advanced stage at diagnosis. Therefore, early detection of this cancer could potentially improve treatment efficacy and reduce mortality.
May 28, 2007 - "Nutra Ingredients", EU
Spinach eaters may have lower ovarian cancer risk
Burly sailors like Popeye may not be the only ones to benefits from spinach, with new research suggesting that women who eat spinach may have a lower risk of ovarian cancer than women who don't. New research, published in the International Journal of Cancer, reports that increased intake of the flavonoid kaempferol, found in spinach and some cabbages, was associated with a 40 per cent reduced risk of ovarian cancer.
May 24, 2007 - "CBS-3 - TV", Philadelphia, PA
Health: Ovarian Cancer
There's a health alert fear of ovarian cancer, the silent killer of women. It's difficult to find and treat and for young women it can destroy their ability to have children. Medical Reporter Stephanie Stahl is has one woman's story of beating the odds.
May 17, 2007 - "The Courier-Journal.", Louisville, KY
Living with cancer
The face of cancer is changing from a death mask to a smiling countenance. Among the happy faces was that of Cheri Hauber, a 48-year-old Douglass Hills woman who has survived both ovarian and uterine cancers.
May 16, 2007 - "Catonsville Times", Catonsville MD
Organizers carry message of hope for cancer fight
Lace up those walking shoes. Catonsville's Relay for Life, a celebration of cancer survivors and those whose loved ones have been touched by cancer, takes place June 9-10 on the track at CCBC-Catonsville.
May 10, 2007 - "NewsRx ", Atlanta, GA
Cancer Gene Therapy
New investigation results, "The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo," are detailed in a study published in Clinical Cancer Research. "Advanced ovarian cancers are initially responsive to combinatorial chemotherapy with platinum drugs and taxanes but, in most cases, develop drug resistance
May 10, 2007 - "The Courier-Journal", Louisville, KY
Ovarian cancer in spotlight
Ovarian Awareness of Kentucky -- a support and resource center for ovarian/gynecological concerns -- recently released a schedule of several 2007 Lunch & Learn programs to raise awareness about ovarian cancer. Each program will include information on risk factors, screening programs and the "not so silent" symptoms.
May 08, 2007 - "Medical News Today", UK
Combined Molecular-targeted And Hormonal Therapies Offer Promise In Treating Ovarian Cancer
A combination of molecular-targeted therapy and hormonal therapy may be the most promising area of research for those seeking an effective treatment for ovarian cancer, according to a new review in the International Journal of Gynecological Cancer.
May 03, 2007 - "Examiner", Denver, CO
Researchers Examine Bio-Magnetic Sensors
Doctors in the future might be able to diagnose breast and ovarian cancer or Alzheimer's disease using magnetism and microscopic particles of iron oxide bound to the type of cells being traced.
May 03, 2007 - "The College Publisher", Radnor, PA
Lack of study in ovarian cancer raises concern
"I was speechless. I was numb. Whether you want to know it or not, they will explain it to you," Sandy Eubank of Riverside, NJ said when she found out she had ovarian cancer.
May 02, 2007 - "Lancaster OnLine", Lancaster, Pa
Out of tragedy, he grew 'Flowers'
Ralph Walls knows firsthand what it's like to deal with tragedy. The Sarasota, Fla., resident lost his first wife to ovarian cancer and one of his good friends in the TWA Flight 800 tragedy in 1996. He also has dealt with the guilt of being mentally abusive to loved ones.
May 02, 2007 - "Medical News Today", UK
New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death
A new study further supports the unique mechanism of action of phenoxodiol, an investigational drug being studied for the treatment of ovarian cancer. The drug appears to work by targeting a certain tumor-specific protein, which triggers a series of events that selectively induce cancer cell death. Phenoxodiol is currently being studied in patients with resistant ovarian cancer, a disease that is estimated to kill more than 15,000 women this year in the U.S. alone.
|
|